
    
      PRS-060 is a drug candidate being developed for the treatment of asthma. The main purpose of
      this study is to investigate the safety, tolerability, and pharmacokinetics of multiple doses
      of PRS-060 administered by inhalation in subjects with mild asthma.
    
  